Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of talc pleurodesis for malignant pleural effusion
CTR20222392Phase 3Active
- Sponsor
- Novatech
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of talc in malignant pleural effusion (MPE), sponsored by Novatech. Started Mar 2023; status: active.
02
Drugs
talc
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on CTR20222392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222392.